<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ECCC96A2-526B-4202-B3E2-547EEB8FE057"><gtr:id>ECCC96A2-526B-4202-B3E2-547EEB8FE057</gtr:id><gtr:name>Newcastle General Hospital</gtr:name><gtr:address><gtr:line1>Westgate Road</gtr:line1><gtr:line2>Newcastle Upon Tyne</gtr:line2><gtr:line3>Tyne and Wear</gtr:line3><gtr:postCode>NE4 6BE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D562BA69-7B29-4D45-B446-25600A221273"><gtr:id>D562BA69-7B29-4D45-B446-25600A221273</gtr:id><gtr:name>Kagoshima University</gtr:name><gtr:address><gtr:line1>Kagoshima University</gtr:line1><gtr:line2>Korimoto</gtr:line2><gtr:postCode>890-8580</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ECCC96A2-526B-4202-B3E2-547EEB8FE057"><gtr:id>ECCC96A2-526B-4202-B3E2-547EEB8FE057</gtr:id><gtr:name>Newcastle General Hospital</gtr:name><gtr:address><gtr:line1>Westgate Road</gtr:line1><gtr:line2>Newcastle Upon Tyne</gtr:line2><gtr:line3>Tyne and Wear</gtr:line3><gtr:postCode>NE4 6BE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D562BA69-7B29-4D45-B446-25600A221273"><gtr:id>D562BA69-7B29-4D45-B446-25600A221273</gtr:id><gtr:name>Kagoshima University</gtr:name><gtr:address><gtr:line1>Kagoshima University</gtr:line1><gtr:line2>Korimoto</gtr:line2><gtr:postCode>890-8580</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ADD8049D-3CA3-403E-907C-BCCAA6D666BC"><gtr:id>ADD8049D-3CA3-403E-907C-BCCAA6D666BC</gtr:id><gtr:firstName>Lars</gtr:firstName><gtr:surname>Fugger</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DB2926BA-C983-407D-8CF8-78F05AD3854A"><gtr:id>DB2926BA-C983-407D-8CF8-78F05AD3854A</gtr:id><gtr:firstName>Angela</gtr:firstName><gtr:surname>Vincent</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B8589B0D-9E61-4F52-BF00-5D59B945DBD9"><gtr:id>B8589B0D-9E61-4F52-BF00-5D59B945DBD9</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Buckley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401222"><gtr:id>92A949CB-CDFB-4197-AB3D-479FD969F856</gtr:id><gtr:title>Pathfinder: GFP-immunisation: a novel approach to generate cell-specific neuronal loss</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401222</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-01-17</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>216774</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Marco Capogna</gtr:description><gtr:id>C93488D3-F416-4068-BBEF-6C387E96E9EA</gtr:id><gtr:impact>21054347 Lalic Tatjana (Jan, 2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission., Epilepsia. 2011 Jan;52(1):121-31.</gtr:impact><gtr:outcomeId>1777988C374-2</gtr:outcomeId><gtr:partnerContribution>Use of novel electrophysiological techniques that otherwise would not have been available to us. Revealed interesting clues to anatomy and pathophysiology.Joint applicants for further funding Improved understanding of neuropsychological aspects of disorders</gtr:partnerContribution><gtr:piContribution>Introduction to the disease and intiation of studies Provision of patient serum Immunohistochemistry Intepreting findings in light of our previous work</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Experimental Psychology</gtr:department><gtr:description>Experimental Psychology</gtr:description><gtr:id>F19AC77A-40A4-4808-9880-EAADCA1FEBA8</gtr:id><gtr:impact>Oral presentation at the International Society of Neuroimmunology, Sitges, 2010.</gtr:impact><gtr:outcomeId>GyVcLQwC2Ua-1</gtr:outcomeId><gtr:partnerContribution>Publication in preparation from joint experiments. They have taught us new techniques to allow us to examine the in vivo effects of our patients' antibodies.
They have also helped design future experiments and shared their expertise in modelling cognition and in hippocampal function</gtr:partnerContribution><gtr:piContribution>We initiated the collaboration and suggested the intial experiments. We have prepared and contributed the patient samples and performed all the experiments and data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Anatomical Neuropharmacology Unit</gtr:department><gtr:description>Marco Capogna</gtr:description><gtr:id>C4DACD4A-0CF7-46E0-900C-6864412D7D12</gtr:id><gtr:impact>21054347 Lalic Tatjana (Jan, 2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission., Epilepsia. 2011 Jan;52(1):121-31.</gtr:impact><gtr:outcomeId>1777988C374-1</gtr:outcomeId><gtr:partnerContribution>Use of novel electrophysiological techniques that otherwise would not have been available to us. Revealed interesting clues to anatomy and pathophysiology.Joint applicants for further funding Improved understanding of neuropsychological aspects of disorders</gtr:partnerContribution><gtr:piContribution>Introduction to the disease and intiation of studies Provision of patient serum Immunohistochemistry Intepreting findings in light of our previous work</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neuroscience</gtr:department><gtr:description>Cunningham</gtr:description><gtr:id>B766108A-60B5-4869-8EF8-7BE68C08CB71</gtr:id><gtr:impact>Publication in press. Follow up studies now in progress.</gtr:impact><gtr:outcomeId>ff9PyW8bT3Y-1</gtr:outcomeId><gtr:partnerContribution>He has generated in vitro data to support the concept of a pathogenic effect of autoantibodies in disorders of the central nervous system</gtr:partnerContribution><gtr:piContribution>We intiated the collaboration and have contibuted patient samples, IgG preparations. In addition we have been actively involved in planning and interpreting the experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kagoshima University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Neurology and Geriatrics</gtr:department><gtr:description>Osamu</gtr:description><gtr:id>4699C444-B75D-4436-978A-41F47060F4AB</gtr:id><gtr:impact>Publication in preparation describing the novel findings that have improved our understanding of the pathophysiology of neuromyotonia</gtr:impact><gtr:outcomeId>triXaCdQAYB-1</gtr:outcomeId><gtr:partnerContribution>They have provided an additional cohort of patients on which to confirm the findings on our cohort</gtr:partnerContribution><gtr:piContribution>We initiated the collaboration in order to ratify results we obtained on our cohort of patients. We have performed a battery of different assays on his cohort of patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle General Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>anderson</gtr:description><gtr:id>5F3BAB32-B285-4A6C-A38A-3EE0ADF85D6F</gtr:id><gtr:impact>20113337 Anderson K N (Aug, 2010) Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder., European journal of neurology : the official journal of the European Federation of Neurological Societies 17, 8, 1105-7</gtr:impact><gtr:outcomeId>mK2CeXeN2jV-1</gtr:outcomeId><gtr:partnerContribution>They provided clinical samples for use in our assay</gtr:partnerContribution><gtr:piContribution>We assayed all the samples using the assay that was optimised as part of this research grant</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Brain awareness week</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4E1B1359-9CCB-412D-A893-BB2B4050F3BE</gtr:id><gtr:impact>Brain Awareness week in the atrium of the neurosciences hospital publicising clinically related research to interested members of the public.

Stimulated patient enquiries for further information about the on-going research.</gtr:impact><gtr:outcomeId>bEhzp8tzGAf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.neuroscience.ox.ac.uk/</gtr:url><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Neurosciences Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5CAEB258-3746-44D0-9290-C045A6A459DA</gtr:id><gtr:impact>increased awareness of our research activity for a broad ranged of neuroscientists and neurologists.

Expression of interest from students keen to undertake postgraduate degrees.</gtr:impact><gtr:outcomeId>eVtEfrkC9c9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stiff Person Syndrome</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D0151538-3FEA-4A05-BA58-A9F8A2E07FF5</gtr:id><gtr:impact>Increased public awareness of our work

More patients requesting involvement in our research projects</gtr:impact><gtr:outcomeId>AayoisJoB9y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in clinical reviews</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C7C8E3DE-5B6A-46FC-81AA-C5AFC30342D0</gtr:id><gtr:impact>The increased recognition and further understanding of these disorders is increasingly disseminating into international clinical practise resulting in improved pateint outcomes as a consequence</gtr:impact><gtr:outcomeId>rvuNJWB76VH</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We are assisting Euroimmune in the development of diagnostic slides for multiple antibody testing on patients with encephalitis</gtr:description><gtr:id>F4F9E837-B462-41F0-8DCF-70D3D293E3D5</gtr:id><gtr:impact>When in routine clinical use these slides will greatly enhance the speed, accuracy and availability of diagnosis of autoimmune encephalopathy in critically ill patients and therefore reduce morbidity and mortality by ensuring prompt administration of appropriate immunotherapy.</gtr:impact><gtr:outcomeId>TSBFj43ykko</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Euroimmune</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Identifying patient samples whom IgG binds to the surface of neuronal cultures, indicating the presence of a pathogenic antibody. This sample is used for immunoprecipitation from cultured cells, to isolate IgG-antigen complexes, which can be processed with western blotting and mass spectrometry techniques to identify novel autoantibodies.</gtr:description><gtr:id>4CC7D41F-E839-4DF5-8FA8-600B59716C16</gtr:id><gtr:impact>Identification of a novel antibody which may be developed into a new diagnostic test, which will be invaluable in the clinical management of challenging patients.</gtr:impact><gtr:outcomeId>UmGedwjcd6w</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Immunoprecipitation/Western blot/ Mass-spectrometry</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AE349AC7-90C2-493B-A9B0-DA1DEA01D8E4</gtr:id><gtr:title>Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_16209_29_24014519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FC07DC5-72D5-49C2-BDF5-E080B573E9E6</gtr:id><gtr:title>Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bad80de2feabbbdf562d8da04879055d"><gtr:id>bad80de2feabbbdf562d8da04879055d</gtr:id><gtr:otherNames>Anderson KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>okasX5Peoaq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>244D1CCC-868F-4A87-AEE9-08F3DF1DD280</gtr:id><gtr:title>Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa92ea8d8f59bb90370c87f200cdd925"><gtr:id>aa92ea8d8f59bb90370c87f200cdd925</gtr:id><gtr:otherNames>Lang B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58ca74edc44db9.54464379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07358C4A-D9E5-4E85-9774-6979E2C111E9</gtr:id><gtr:title>Immunotherapy-responsive seizure-like episodes with potassium channel antibodies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>3991728B51C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91744CF0-8802-4EE7-B98E-BBBB68FC044D</gtr:id><gtr:title>Republished review: Autoantibody testing in encephalopathies.</gtr:title><gtr:parentPublicationTitle>Postgraduate medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056d842d169854930e5220ad3da15f14"><gtr:id>056d842d169854930e5220ad3da15f14</gtr:id><gtr:otherNames>Lee R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0032-5473</gtr:issn><gtr:outcomeId>pm_16209_29_22523311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D9A2138-EFA0-413C-B9F9-0717E05DFD0C</gtr:id><gtr:title>Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/209f39b43a0a141b3a9fcc985f600ddd"><gtr:id>209f39b43a0a141b3a9fcc985f600ddd</gtr:id><gtr:otherNames>Chang T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54643d5557ccf7.41388258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAD9969F-40F8-410E-BDB4-AF293FEA1972</gtr:id><gtr:title>Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a5a55005682573810740bce565abd5"><gtr:id>49a5a55005682573810740bce565abd5</gtr:id><gtr:otherNames>Leite MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_16209_29_22551731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A94ECA3-D326-4A3D-9F92-CC1668A56457</gtr:id><gtr:title>Adaptive sugar sensors in hypothalamic feeding circuits.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2052982e09053c07158b4473ba838ee7"><gtr:id>2052982e09053c07158b4473ba838ee7</gtr:id><gtr:otherNames>Williams RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Zo4122h4aFA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9116700-DA47-4FE5-8991-E20644B4A260</gtr:id><gtr:title>Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ece16b8d922cfed620a6987d16a9d2"><gtr:id>59ece16b8d922cfed620a6987d16a9d2</gtr:id><gtr:otherNames>Burdakov D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>Qmsb9U1jXNC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B640095A-DA86-4855-9137-CD0E87FAC7D3</gtr:id><gtr:title>Clinical spectrum of voltage-gated potassium channel autoimmunity.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/574f973bede4fd9f446edfa9f6f58020"><gtr:id>574f973bede4fd9f446edfa9f6f58020</gtr:id><gtr:otherNames>Vincent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>1102B5FF2BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41DFD44E-AFD5-4281-9F7A-9E5F0084AB0C</gtr:id><gtr:title>Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>fV49zP5vTbn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38845EDF-2C85-45F8-8EEA-ED92523A0DBD</gtr:id><gtr:title>Modelling autoimmune narcolepsy in humanised mice</gtr:title><gtr:parentPublicationTitle>JOURNAL OF NEUROIMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4415222071d5efacf9d94c0dd87df94e"><gtr:id>4415222071d5efacf9d94c0dd87df94e</gtr:id><gtr:otherNames>Haris Alexopoulos</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0165-5728</gtr:issn><gtr:outcomeId>Mta2QtVvJ7t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F87A5A7A-EAFE-4FF1-B335-0DD9FD2EE21A</gtr:id><gtr:title>Antibodies to the VGKC-Complex Proteins LGI1 and CASPR2 in Acquired Neuromyotonia</gtr:title><gtr:parentPublicationTitle>ANNALS OF NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/656d9b4742025e17fcc7c32d3db849f4"><gtr:id>656d9b4742025e17fcc7c32d3db849f4</gtr:id><gtr:otherNames>Buckley Camilla</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>T6ARvmo5WGW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7914D535-176B-4F9A-A176-2EDD867B7431</gtr:id><gtr:title>MORVAN'S SYNDROME: CLINICAL AND SEROLOGICAL FINDINGS IN 27 CASES</gtr:title><gtr:parentPublicationTitle>EUROPEAN JOURNAL OF NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/535e718b51c2e5f9e15e0c49aabeaf1e"><gtr:id>535e718b51c2e5f9e15e0c49aabeaf1e</gtr:id><gtr:otherNames>Irani S. R.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>aNSYgBgY2EK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>712BD35F-508A-480D-968C-FFFAEBAD2AD7</gtr:id><gtr:title>Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32a388815089d258611a872ff9c2dd96"><gtr:id>32a388815089d258611a872ff9c2dd96</gtr:id><gtr:otherNames>Dawes JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>5aa8fdc3221fc8.05871291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8FE74C4-6401-4FA5-AA5C-E0CE16AA2A53</gtr:id><gtr:title>Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6de0cf39546b886a007792ec7bf07dd3"><gtr:id>6de0cf39546b886a007792ec7bf07dd3</gtr:id><gtr:otherNames>Loukaides P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>HUnGLc1A5FH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70CA7F5D-B16E-43A0-BDAE-982478029D34</gtr:id><gtr:title>Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>AnSrjSV3H2p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9627E141-451E-455C-961C-312BBD6AD66F</gtr:id><gtr:title>Autoantibodies to GAD and Cell Surface Determinants in Stiff Person Syndrome</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2849a93fac1dfc4386fd9716cafac4a1"><gtr:id>2849a93fac1dfc4386fd9716cafac4a1</gtr:id><gtr:otherNames>Chang Thashi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>dvnshhoG6Wm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30115B39-6888-4FD7-B49A-AAE989795483</gtr:id><gtr:title>Autoantibody testing in encephalopathies.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056d842d169854930e5220ad3da15f14"><gtr:id>056d842d169854930e5220ad3da15f14</gtr:id><gtr:otherNames>Lee R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>pm_16209_29_22258167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88228DAE-E9F0-42FD-821C-AA9C45CC8806</gtr:id><gtr:title>Morvan syndrome: clinical and serological observations in 29 cases.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_16209_29_22473710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33FC2F75-35E0-4F89-AA05-E068F714782B</gtr:id><gtr:title>Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>pm_16209_29_22120595</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401222</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>